Active	Status	Sponsor type	Region	Phase	Filter
7 Active 2 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MAURIER, François
NERF-VASC, NCT05164822: Evolution of Neuropathies Associated With Necrotizing Vasculitis	Terminated	N/A	10	Europe	Necrotizing Vasculitis	Lille Catholic University, UNEOS	Necrotizing Vasculitis, Neuropathy	10/22	10/22
MAINEPSAN, NCT03290456 / 2018-001215-69: Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.	Recruiting	N/A	146	Europe	Prednisone 5mg/day extended of 12 additional months, Placebo 5mg/day extended of 12 additionnal months.	Hospices Civils de Lyon, Ministry of health	Granulomatosis With Polyangitis	06/24	06/24
SCLEROMICS, NCT02298777: Metabolomic Analysis of Systemic Sclerosis	Recruiting	N/A	140	Europe	- Skin biopsy - Urine sample - Blood sample	University Hospital, Strasbourg, France	Scleroderma (Limited and Diffuse), Undifferentiated Connective Tissue Disease, Raynaud Disease, Vascular Disease, Healthy Control Subjects	12/25	02/26
Campagne, Julien
RENATO, NCT05946564: A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - Trial	Recruiting	3	126	Europe	Pioglitazone (ACTOS®), Placebo of Pioglitazone	Assistance Publique - Hôpitaux de Paris, Ministry of Health, France	ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis	04/27	10/27
NERF-VASC, NCT05164822: Evolution of Neuropathies Associated With Necrotizing Vasculitis	Terminated	N/A	10	Europe	Necrotizing Vasculitis	Lille Catholic University, UNEOS	Necrotizing Vasculitis, Neuropathy	10/22	10/22
OPTIMISE, NCT05763225: Validation of Patient E-tool to Measure Systemic Lupus Activity	Completed	N/A	450	Europe, RoW		Association Francaise du Lupus et Autres Maladies Auto-immunes (AFL+), Hometrix Health SAS	Lupus Erythematosus, Systemic	06/24	06/24
CYTILDASS, NCT05984394: Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease	Recruiting	N/A	24	Europe	BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT	Central Hospital, Nancy, France	Antisynthetase Syndrome	10/25	10/25